Cargando…

HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus

BACKGROUND: The interplay between HCV, DM, and DAA therapy is poorly understood. We compared HCV infection characteristics, treatment uptake, and treatment outcomes in patients with and without DM. METHODS: A retrospective cohort study was conducted using data from The Ottawa Hospital Viral Hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angel, Marina, Petrosyan, Yelena, Doyle, Mary-Anne, Cooper, Curtis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652941/ https://www.ncbi.nlm.nih.gov/pubmed/36371200 http://dx.doi.org/10.1186/s12902-022-01198-x

Ejemplares similares

Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial
por: Doyle, Mary-Anne, et al.
Publicado: (2016)

Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal
por: Parmar, Parmvir, et al.
Publicado: (2016)

Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report
por: Doyle, Mary-Anne, et al.
Publicado: (2015)

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision
por: Cooper, Curtis L, et al.
Publicado: (2010)

Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8(+) T-Cells in Advanced Liver Disease
por: Vranjkovic, Agatha, et al.
Publicado: (2019)

2563. The Impact of HCV Educational Training on HIV Providers’ Attitudes, Knowledge, and Uptake of Treatment Initiation in HCV/HIV Co-infected Patients
por: Lau, Abby A, et al.
Publicado: (2019)

Association of HCV with diabetes mellitus: an Egyptian case-control study
por: Elhawary, Eman I, et al.
Publicado: (2011)

1062. HCV GET-UP: A Group Evaluation and Treatment Uptake Intervention Improves HCV Linkage to Care for PWID
por: Norton, Brianna L, et al.
Publicado: (2020)

Alcohol and HCV Chronic Infection Are Risk Cofactors of Type 2 Diabetes Mellitus for Hepatocellular Carcinoma in Italy
por: Balbi, Massimiliano, et al.
Publicado: (2010)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging
por: Golizeh, Makan, et al.
Publicado: (2018)

Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus
por: Li, Fang, et al.
Publicado: (2021)

The role of HCV proteins on treatment outcomes
por: Kumthip, Kattareeya, et al.
Publicado: (2015)

Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2011)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
por: Emery, Joel, et al.
Publicado: (2010)

The Impact of Mevastatin on HCV Replication and Autophagy of Non-Transformed HCV Replicon Hepatocytes Is Influenced by the Extracellular Lipid Uptake
por: Vescovo, Tiziana, et al.
Publicado: (2019)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese
por: Lim, Yun-Ping, et al.
Publicado: (2013)

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
por: Brandolini, Micaela, et al.
Publicado: (2013)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Characteristics and outcome of spontaneous bacterial meningitis in patients with diabetes mellitus
por: Pomar, Virginia, et al.
Publicado: (2020)

Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes
por: Luo, Ping, et al.
Publicado: (2023)

HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study
por: Cooper, Curtis L., et al.
Publicado: (2019)

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
por: Cooper, Curtis L., et al.
Publicado: (2020)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
por: Triplitt, Curtis, et al.
Publicado: (2015)

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015)

Treatment of Chronic HCV Infection in Special Populations
por: Hoefs, John, et al.
Publicado: (2006)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study
por: Swe, Thein Min, et al.
Publicado: (2023)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Correction to: HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study
por: Cooper, Curtis L., et al.
Publicado: (2019)

Clinical Characteristics and Treatment Efficasy of Chronic HCV Infection Among Intravenous Drug Users in Tuzla Canton
por: Petrovic, Jasminka, et al.
Publicado: (2018)

Evaluating quality of overall care among older adults with diabetes with comorbidities in Ontario, Canada: a retrospective cohort study
por: Petrosyan, Yelena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d60ao0ls75miccvb37i173aruq